Valsartan is a blood pressure drug that trades under the brand name Diovan. In 2018, the FDA announced a series of voluntary recalls by manufacturers of valsartan due to the presence of certain impurities in a number of batches of the medication.
These impurities were carcinogenic, which means that they may have increased the risk of users developing cancer. While manufacturers have cleared up this issue since its discovery, many valsartan patients may have been exposed to severe cancer risk while these impurities were present.
If you were taking valsartan in the period leading up to its recall, you may be entitled to compensation from the manufacturers.
If this is your situation, you need to learn more about valsartan lawsuits and whether you might be entitled to take a case.
What Is Valsartan?
<img cla